{"id":"W2023428359","doi":"10.1016/j.clml.2014.12.015","title":"Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Roche","keywords":"Medicine; Internal medicine; Rituximab; Oncology; Plerixafor; Transplantation; Hematopoietic stem cell transplantation; Lymphoma; Autologous stem-cell transplantation; Vincristine; Chemoimmunotherapy; Etoposide; Progression-free survival; Cyclophosphamide; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001843144,0.0002028457,0.0004865155,0.000189372,0.000417346,0.0006186567,0.0002190808,0.0004018209,0.001230642],"category_scores_gemma":[0.0006068222,0.0001119333,0.00063016,0.0002628962,0.0002634035,0.0003007055,0.0003166002,0.0005018114,0.0002549894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005959612,"about_ca_system_score_gemma":0.0003011533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001572666,"about_ca_topic_score_gemma":0.001694336,"domain_scores_codex":[0.9998304,0.00003261849,0.00001472245,0.00002701959,0.00001745699,0.0000777485],"domain_scores_gemma":[0.9996365,0.00007070146,0.00007937037,0.00001356033,0.00002469938,0.0001752131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02429917,0.001300515,0.9213007,0.00009496994,0.0005695409,0.01173498,0.0003464536,0.002025659,0.005549134,0.0003030474,0.001335422,0.03114031],"study_design_scores_gemma":[0.0009645409,0.0127491,0.9658771,0.00004617802,0.0006407769,0.01457184,0.0003999405,0.00161375,0.0009505312,0.0003239501,0.001823121,0.00003919574],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977674,0.0006645102,0.00008231835,0.00007460527,0.00001671397,0.00001074769,0.0001264673,0.000004451463,0.001252757],"genre_scores_gemma":[0.9991793,0.0001465481,0.00002134032,0.00006375345,0.00002812198,0.000005793599,0.0003371059,0.000001837617,0.0002162168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001572666,"threshold_uncertainty_score":0.004324019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02383174685501354,"score_gpt":0.2816511669996116,"score_spread":0.257819420144598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}